Stroke PreventionSTEPSNCT02591394
STEPs to Blood Pressure Reduction.
A study testing STEP Clinic in people with Stroke Prevention and Blood Pressure Reduction, run by The University of Texas Health Science Center, Houston at 1 site in United States.
Trial summary
The Stroke Transitions Education and Prevention (STEP) Clinic is a new type of clinic designed for stroke patients and was established to provide a comprehensive approach to stroke risk factor reduction. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke Prevention, Blood Pressure Reduction
- What is being tested?
- STEP Clinic
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 115 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2015to 15 Jan 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 18
- Clinical ischemic stroke, intracerebral hemorrhage, or transient ischemic attack
- Plan to discharge home or to short stay inpatient rehab after stroke
- Two of following required:
- History of hypertension (prior to hospitalization)
- Hospital blood pressure ≥ 140/90 on two or more occasions during hospitalization
- Discharge home on blood pressure medication
- Willingness and ability to follow-up in University of Texas Physicians stroke clinic
Who cannot join
- Modified Rankin scale (mRs) > 3 at enrollment
- Terminal illness
- Chronic kidney disease stage 4 or greater (eGFR < 30)
- Pregnancy
- Symptomatic flow limiting carotid stenosis without plan for intervention prior to clinic visit
- Stroke etiology presumed unrelated to atherosclerotic risk factors (amyloid angiopathy, vasculitis, malignancy associated)
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Texas Health Science Center at Houston
Houston, Texas, 77030
About this study
Official title: STEPs to Blood Pressure Reduction. A Randomized Clinical Trial of the Stroke Transitions, Education, and Prevention Clinic Versus Usual Care for Post-Stroke Blood Pressure Reduction
The Stroke Transitions Education and Prevention (STEP) Clinic is a new type of clinic designed for stroke patients and was established to provide a comprehensive approach to stroke risk factor reduction. The goal of this study will be more effective than usual care at reducing blood pressure in patients with poorly controlled blood pressure after an ischemic or hemorrhagic stroke or transient ischemic attack.
Read the detailed description
STEP clinic patients will receive personalized goals, instructions to self-monitor, a blood pressure monitor, prescription medications, sleep apnea screening, dietary counseling, and more frequent follow-up if needed. A stroke neurologist will see patients in the usual care group and recommendations will be sent to their primary care providers.
- Conditions
- Stroke Prevention, Blood Pressure Reduction
- Being tested
- STEP Clinic, Usual Care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
STEP ClinicBehavioural
Patients will visit with STEP clinic staff (including a stroke nurse practitioner or stroke doctor) to receive personalized goals, stroke education (including diet and exercise), instructions to self-monitor using blood pressure cuff, and prescription medications Patient will be scheduled for additional clinic follow-up or be contacted for telephone follow-up for management of your blood pressure. Questionnaires will be administered to determine medication adherence and persistence (following instructions for prescribed medication), disability, depression, cognition, self-efficacy, and sleep apnea. The care plan determined by the STEP clinic will be shared with the patient's primary care provider.
Usual CareBehavioural
Patients will complete questionnaires related to medical history and health behaviors prior to initial visit.
After being seen by the stroke neurologist, patients may be scheduled to return to the stroke clinic according the doctor's recommendations.
Recommendations for blood pressure and risk factor monitoring will be sent to primary care providers.
| Study group | Role | What they receive |
|---|---|---|
| STEP Clinic | Experimental | Not described Receives: Behavioral: STEP Clinic |
| Usual Care | Active comparator | Not described Receives: Behavioral: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Daytime ambulatory systolic blood pressure
Measured: 6 months
Secondary outcomes (12)
Daytime ambulatory diastolic blood pressure
Measured: 6 months
Nighttime ambulatory systolic blood pressure
Measured: 6 months
Nighttime ambulatory diastolic c blood pressure
Measured: 6 months
Number of patients achieving blood pressure control at 6 months as assessed by ambulatory blood pressure
Measured: 6 months
Number of patients achieving blood pressure control at 6 months as assessed by automated office blood pressure
Measured: 6 months
Number of participants who are adherent to blood pressure medications
Measured: 6 months
Depressive Symptoms as assessed by Patient Health Questionnaire 9
Measured: 6 months
Number of patient monitoring blood pressure at home
Measured: 6 months
Satisfaction with Social Roles and activities as measured by NeuroQuality of Life short form
Measured: 6 months
Satisfactions with stroke clinic as assessed by Consumer Assessment of Healthcare Providers and Systems Survey
Measured: 6 months
Self Efficacy as Assessed by Medication Adherence Self-Efficacy Scale
Measured: 6 months
Number of composite cardiovascular events
cardiac death, myocardial infarction, ischemic stroke, hemorrhagic stroke
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2015 (estimated)
- Study startNov 2015
- Primary completion15 Jan 2019
- Study completion15 Jan 2019
Why it stopped: Funding period ended and slow enrollment
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Stroke PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 115 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Sponsor type
- University, hospital or other
- Collaborators
- Georgetown University
- Responsible party
- Principal investigator, Anjail Z Sharrief, The University of Texas Health Science Center, Houston
- Investigators
- Anjail Z Sharrief, MD MPH, Principal investigator, The University of Texas Health Science Center, Houston
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02591394
- Sponsor's protocol ID
- HSC-MS-15-0416
- Acronym
- STEPS
- Status last verified
- Sep 2020
- First submitted
- 28 Oct 2015
- Last updated
- 10 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
Publications
Sharrief AZ, Hinojosa E, Cooksey G, Okpala MN, Avritscher EB, Pedroza C, Denny MC, Samuels J, Tyson JE, Savitz SI. Does care in a specialised stroke prevention clinic improve poststroke blood pressure control: a protocol for a randomised comparative effectiveness study. BMJ Open. 2019 Feb 19;9(2):e024695. doi: 10.1136/bmjopen-2018-024695.
PubMed 30782915
Study at a glance
From the registry record, last updated by the sponsor on 10 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- STEPs to Blood Pressure Reduction. A Randomized Clinical Trial of the Stroke Transitions, Education, and Prevention Clinic Versus Usual Care for Post-Stroke Blood Pressure Reduction
- ClinicalTrials.gov ID
- NCT02591394
- Acronym / sponsor ID
- STEPS / HSC-MS-15-0416
- Conditions
- Stroke Prevention, Blood Pressure Reduction
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Funding period ended and slow enrollment
- Enrolment
- 115 participants (actual)
- Lead sponsor
- The University of Texas Health Science Center, HoustonUniversity, hospital or other
- Collaborators
- Georgetown University
- Study start
- Nov 2015
- Primary completion
- 15 Jan 2019 (actual)
- Study completion
- 15 Jan 2019 (actual)
- First posted
- 29 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Stroke Transitions Education and Prevention (STEP) Clinic is a new type of clinic designed for stroke patients and was established to provide a comprehensive approach to stroke risk factor reduction. The goal of this study will be more effective than usual care at reducing blood pressure in patients with poorly controlled blood pressure after an ischemic or hemorrhagic stroke or transient ischemic attack.
Detailed description
STEP clinic patients will receive personalized goals, instructions to self-monitor, a blood pressure monitor, prescription medications, sleep apnea screening, dietary counseling, and more frequent follow-up if needed. A stroke neurologist will see patients in the usual care group and recommendations will be sent to their primary care providers.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| STEP Clinic | Experimental | Behavioral: STEP Clinic |
| Usual Care | Active comparator | Behavioral: Usual Care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Age ≥ 18
- Clinical ischemic stroke, intracerebral hemorrhage, or transient ischemic attack
- Plan to discharge home or to short stay inpatient rehab after stroke
- Two of following required:
- History of hypertension (prior to hospitalization)
Key exclusion criteria (6 listed)
- Modified Rankin scale (mRs) > 3 at enrollment
- Terminal illness
- Chronic kidney disease stage 4 or greater (eGFR < 30)
- Pregnancy
- Symptomatic flow limiting carotid stenosis without plan for intervention prior to clinic visit
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| STEP ClinicPatients will visit with STEP clinic staff (including a stroke nurse practitioner or stroke doctor) to receive personalized goals, stroke education (including diet and exercise), instructions to self-monitor using blood pressure cuff, and prescription medications Patient will be scheduled for additional clinic follow-up or be contacted for telephone follow-up for management of your blood pressure. Questionnaires will be administered to determine medication adherence and persistence (following instructions for prescribed medication), disability, depression, cognition, self-efficacy, and sleep apnea. The care plan determined by the STEP clinic will be shared with the patient's primary care provider. | Behavioural | STEP Clinic |
| Usual CarePatients will complete questionnaires related to medical history and health behaviors prior to initial visit. After being seen by the stroke neurologist, patients may be scheduled to return to the stroke clinic according the doctor's recommendations. Recommendations for blood pressure and risk factor monitoring will be sent to primary care providers. | Behavioural | Usual Care |
Primary outcome
Daytime ambulatory systolic blood pressure
Time frame: 6 months
12 secondary outcomes
Daytime ambulatory diastolic blood pressure
Time frame: 6 months
Nighttime ambulatory systolic blood pressure
Time frame: 6 months
Nighttime ambulatory diastolic c blood pressure
Time frame: 6 months
Number of patients achieving blood pressure control at 6 months as assessed by ambulatory blood pressure
Time frame: 6 months
Number of patients achieving blood pressure control at 6 months as assessed by automated office blood pressure
Time frame: 6 months
Number of participants who are adherent to blood pressure medications
Time frame: 6 months
Depressive Symptoms as assessed by Patient Health Questionnaire 9
Time frame: 6 months
Number of patient monitoring blood pressure at home
Time frame: 6 months
Satisfaction with Social Roles and activities as measured by NeuroQuality of Life short form
Time frame: 6 months
Satisfactions with stroke clinic as assessed by Consumer Assessment of Healthcare Providers and Systems Survey
Time frame: 6 months
Self Efficacy as Assessed by Medication Adherence Self-Efficacy Scale
Time frame: 6 months
Number of composite cardiovascular events
Time frame: 6 months
Results and safety
The study was stopped early (reason given: Funding period ended and slow enrollment). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Sep 2020.
- Derived from this study: PubMed 30782915Sharrief AZ, Hinojosa E, Cooksey G, Okpala MN, Avritscher EB, Pedroza C, Denny MC, Samuels J, Tyson JE, Savitz SI. Does care in a specialised stroke prevention clinic improve poststroke blood pressure control: a protocol for a randomised comparative effectiveness study. BMJ Open. 2019 Feb 19;9(2):e024695. doi: 10.1136/bmjopen-2018-024695.
Related trials for Stroke Prevention
Recruiting
OPTION-EMEA Clinical Trial
Atrial Fibrillation (AF), Stroke Prevention in Patients With Atrial Fibrillation
RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Not yet recruitingPhase 3
Cilostazol for Prevention of Recurrent Stroke Trial
Stroke Recurrence, Myocardial Infarction
RecruitingPhase 3
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Stroke, Ischemic
Active, not recruitingPhase 2
Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
Sickle Cell Anemia in Children
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anjail Z Sharrief, MD MPH principal investigator
The University of Texas Health Science Center, Houston
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing STEP Clinic in people with Stroke Prevention and Blood Pressure Reduction, run by The University of Texas Health Science Center, Houston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 10 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Funding period ended and slow enrollment). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Daytime ambulatory systolic blood pressure (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02591394, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2020.